AB
VIR icon

Amalgamated Bank’s Vir Biotechnology VIR Stock Holding History

Amalgamated Bank’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Buy
32,659
+908
+3% +$8.64K ﹤0.01% 1469
2026
Q1 		$284K Buy
31,751
+4,829
+18% +$38.5K ﹤0.01% 1482
2025
Q4 		$162K Sell
26,922
-272
-1% -$1.62K ﹤0.01% 1609
2025
Q3 		$155K Buy
27,194
+931
+4% +$4.76K ﹤0.01% 1630
2025
Q2 		$132K Hold
26,263
– – ﹤0.01% 1653
2025
Q1 		$170K Sell
26,263
-300
-1% -$2.67K ﹤0.01% 1569
2024
Q4 		$195K Sell
26,563
-172
-0.6% -$1.36K ﹤0.01% 1580
2024
Q3 		$200K Buy
26,735
+995
+4% +$8.64K ﹤0.01% 1585
2024
Q2 		$229K Sell
25,740
-2,032
-7% -$19.5K ﹤0.01% 1547
2024
Q1 		$281K Sell
27,772
-4,698
-14% -$47.8K ﹤0.01% 1503
2023
Q4 		$327K Sell
32,470
-1,159
-3% -$10.6K ﹤0.01% 1610
2023
Q3 		$315K Buy
33,629
+2,511
+8% +$35.8K ﹤0.01% 1610
2023
Q2 		$763K Sell
31,118
-423
-1% -$10.6K 0.01% 1245
2023
Q1 		$734K Sell
31,541
-2,508
-7% -$64.1K 0.01% 1242
2022
Q4 		$862K Buy
34,049
+228
+0.7% +$5.59K 0.01% 1207
2022
Q3 		$652K Buy
33,821
+704
+2% +$17.9K 0.01% 1297
2022
Q2 		$843K Buy
33,117
+23,314
+238% +$544K 0.01% 1210
2022
Q1 		$252K Sell
9,803
-776
-7% -$23K ﹤0.01% 1846
2021
Q4 		$443K Sell
10,579
-115
-1% -$4.5K ﹤0.01% 1639
2021
Q3 		$465K Sell
10,694
-659
-6% -$28.5K ﹤0.01% 1617
2021
Q2 		$537K Buy
11,353
+3,725
+49% +$169K ﹤0.01% 1603
2021
Q1 		$391K Sell
7,628
-744
-9% -$40.1K 0.01% 1115
2020
Q4 		$224K Buy
8,372
+41
+0.5% +$1.33K 0.01% 1388
2020
Q3 		$286K Buy
8,331
+922
+12% +$39.7K 0.01% 1133
2020
Q2 		$304K Buy
+7,409
New +$249K 0.01% 1096

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
SAI
Savvy Advisors Inc New York $4.71B AUM 25.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.6B AUM 24.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return

Amalgamated Bank's VIR Position: Q2 2026 in Review

Amalgamated Bank increased its Vir Biotechnology (VIR) stake by 2.9% in Q2 2026, buying an estimated $8.64K and bringing the position to 32,659 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #1469.

Amalgamated Bank first reported a position in VIR in Q2 2020 and has held it in 25 quarters since. The position peaked at $862K in Q4 2022. 89 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Amalgamated Bank held 32,659 shares of Vir Biotechnology worth $333K as of Q2 2026.
  • Amalgamated Bank bought 908 Vir Biotechnology shares in Q2 2026, an estimated $8.64K.
  • Vir Biotechnology made up ﹤0.01% of Amalgamated Bank's portfolio in Q2 2026, its #1469 holding.
  • Amalgamated Bank first reported a position in Vir Biotechnology in Q2 2020 and has held it in 25 quarters since.
  • Amalgamated Bank's Vir Biotechnology position peaked at $862K in Q4 2022.
  • 89 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.